Literature DB >> 3347009

Depletion of serum holotranscobalamin II. An early sign of negative vitamin B12 balance.

B Herzlich1, V Herbert.   

Abstract

Preferential depletion of corrinoids on transcobalamin II (i.e., sharply reduced holo transcobalamin II (TC II)) occurs early in vitamin B12 deficiency. We measured corrinoids (Cor) and cobalamins (Cbl) on transcobalamins I and III (TC I + III) and on TC II. We also measured the unsaturated B12 binding capacities of transcobalamin I and III and TC II in serum from patients with B12 deficiency (N = 5) (with or without concurrent folate deficiency), with pernicious anemia in remission (N = 7) (1 month after therapy), and in several control groups including healthy volunteers (N = 6), hematologically normal elderly hospitalized patients (N = 5), and non-B12 nonfolate deficient anemic elderly hospitalized volunteers (N = 5). In B12 deficient patients, Cor = 177 +/- 92 pg/ml, Cbl = 56 +/- 20 pg/ml, TC II Cor = 1.0 +/- 2.2 pg/ml, and TC II Cbl = 4.4 +/- 4.9 pg/ml in contrast to pooled controls with Cor = 730 +/- 229, Cbl = 523 +/- 198, TC II Cor = 100 +/- 84, and TC II Cbl = 88 +/- 70 (all values expressed in picograms/milliliters). In pernicious anemia in remission, Cor = 505 +/- 138, Cbl = 294 +/- 77, TC II Cor = 80 +/- 31 and TC II Cbl = 37 +/- 36. TC II unsaturated B12 binding capacity was significantly higher in B12 deficient patients than in pooled controls. These data support that: (a) holo TC II is sharply depleted in untreated B12 deficiency; (b) normally, the only Cor on TC II are cobalamins; (c) in treated pernicious anemia, TC II appears to also bind non-cobalamin corrinoids; (d) continued malabsorption of vitamin B12 may result in reduced B12 on TC II within a month after the last parenteral therapy with 1000 micrograms of cyanocobalamin, and (e) TC II UBBC rises as B12 deficiency is developing. Further investigation is required for definitive delineation of whether sharply reduced Cor on TC II in untreated B12 deficiency can diagnose "true" B12 deficiency, in view of false positive or false negative results which occur in all serum B12 assays.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3347009

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

Review 1.  Nutritional supplements in the ambulatory geriatric population. Should they be recommended?

Authors:  M L Freedman
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

2.  Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocytosis.

Authors:  S N Wickramasinghe; I D Ratnayaka
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

Review 3.  B12 binding proteins.

Authors:  G Neale
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

Review 4.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

Review 5.  Cellular uptake of cobalamin: transcobalamin and the TCblR/CD320 receptor.

Authors:  Edward V Quadros; Jeffrey M Sequeira
Journal:  Biochimie       Date:  2013-02-14       Impact factor: 4.079

6.  X-ray structural characterization of imidazolylcobalamin and histidinylcobalamin: cobalamin models for aquacobalamin bound to the B12 transporter protein transcobalamin.

Authors:  Luciana Hannibal; Scott D Bunge; Rudi van Eldik; Donald W Jacobsen; Christoph Kratky; Karl Gruber; Nicola E Brasch
Journal:  Inorg Chem       Date:  2007-04-04       Impact factor: 5.165

Review 7.  Advances in the understanding of cobalamin assimilation and metabolism.

Authors:  Edward V Quadros
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

8.  Correlations between holo-transcobalamin II, holo-haptocorrin, and total B12 in serum samples from healthy subjects and patients.

Authors:  S N Wickramasinghe; S Fida
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

9.  Relationship Between the Levels of Holotranscobalamin and Vitamin B12 in Children.

Authors:  Ikbal Ok Bozkaya; Nese Yarali; Murat Kizilgün; Secil Ozkan; Bahattin Tunc
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-09       Impact factor: 0.900

Review 10.  Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility.

Authors:  Ebba Nexo; Elke Hoffmann-Lücke
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.